# Adagene Inc. > Alpha governed public record. Unknown, unavailable, and unpublished values are never inferred as zero. ## Record | Field | Value | | --- | --- | | Representation | alpha-profile-markdown-v3 | | Protocol | Alpha Governance Facts Protocol 0.1 | | Schema | alpha.governance.entity.public.v1 | | Record version | public-1 | | Canonical entity | alpha:company:b925afbb-e483-491c-b195-7a680f06601e | | Entity type | Company | | Canonical URL | https://registry.alpha.ac/companies/adagene-inc | | Publication | PUBLISHED | | Verification | source_reported | | Verification schema | alpha-verification-states-v1 | | Ownership | unclaimed | | Published claims | 22 | | Claims under review | 1 | | Evidence records | 2 | | Conflicts | 0 | | Conflicts in internal review | 0 | | Observed | 2026-09-12T21:32:05.800844+00:00 | | Last reviewed | 2026-09-12T21:32:05.800844+00:00 | ## Identity - Legal name: Adagene Inc. - Display name: Adagene Inc. ## Leadership - Peter Luo, Ph.D: Co-Founder, Chief Executive Officer, President of R&D, and Chairman of the Board. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:b925afbb-e483-491c-b195-7a680f06601e:2. - Andy (Yiu Leung) Cheung: Independent Director. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:b925afbb-e483-491c-b195-7a680f06601e:2. - Cuong Do: Independent Director. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:b925afbb-e483-491c-b195-7a680f06601e:2. - Li Zhu, Ph.D.: Independent Director. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:b925afbb-e483-491c-b195-7a680f06601e:2. - Man Kin (Raymond) Tam, M.B.A., B. Eng.: Chief Financial Officer and Director. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:b925afbb-e483-491c-b195-7a680f06601e:2. - Ulf Grawunder, Ph.D.: Independent Director. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:b925afbb-e483-491c-b195-7a680f06601e:2. - Alexander Goergen: Vice President, Head of Business Development. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:b925afbb-e483-491c-b195-7a680f06601e:2. - Guizhong Liu, Ph.D.: Senior Vice President of Early Drug Discovery. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:b925afbb-e483-491c-b195-7a680f06601e:2. - Jiping Zha: Executive Vice President of Clinical Development. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:b925afbb-e483-491c-b195-7a680f06601e:2. - Man Kin (Raymond) Tam, M.B.A., B. Eng.: Chief Financial Officer and Director. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:b925afbb-e483-491c-b195-7a680f06601e:2. - Mickael Chane-Du: Chief Strategy Officer. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:b925afbb-e483-491c-b195-7a680f06601e:2. - Peter Luo, Ph.D: Co-Founder, Chief Executive Officer, President of R&D, and Chairman of the Board. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:b925afbb-e483-491c-b195-7a680f06601e:2. - Qinghai Zhao, Ph.D: Chief Manufacturing Officer. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:b925afbb-e483-491c-b195-7a680f06601e:2. - Songmao Zheng, Ph.D.: Senior Vice President of Clinical Pharmacology and Quantitative Sciences. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:b925afbb-e483-491c-b195-7a680f06601e:2. - Wenlin Zeng: Vice President of Early Stage CMC. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:b925afbb-e483-491c-b195-7a680f06601e:2. - Xiaohong (Kristine) She: Senior Vice President, Head of Clinical Operations. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:b925afbb-e483-491c-b195-7a680f06601e:2. - Yan Li, M.B.A.: Senior Vice President, Bioinformatics and Information Technology. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:b925afbb-e483-491c-b195-7a680f06601e:2. ## Roles - PUBLISHED ## Governance - NOT_ASSERTED ## Board committees - PUBLISHED ## Financials - NOT_ASSERTED ## Workforce - NOT_ASSERTED ## Market and index context - PUBLISHED ## Legal Name - Adagene Inc.. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:b925afbb-e483-491c-b195-7a680f06601e:1. ## Headquarters - US. Publication: UNDER_REVIEW. Verification: source_reported. Assertion: source_reported. Evidence: unlinked, under review. ## Entity Status - Public listing published. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:b925afbb-e483-491c-b195-7a680f06601e:1. ## Published Fact - US. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:b925afbb-e483-491c-b195-7a680f06601e:1. - Healthcare. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:b925afbb-e483-491c-b195-7a680f06601e:1. - Biotechnology. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:b925afbb-e483-491c-b195-7a680f06601e:1. ## Coverage states | Field | Value | | --- | --- | | Identity | PUBLISHED | | Business | PUBLISHED | | Leadership | PUBLISHED | | Board and committees | PUBLISHED | | Governance | NOT_ASSERTED | | Financials | NOT_ASSERTED | | Workforce | NOT_ASSERTED | | Ownership | NOT_ASSERTED | | Ratings | NOT_PUBLISHED | | Market and index context | PUBLISHED | ## Public sources - alpha:evidence:company:b925afbb-e483-491c-b195-7a680f06601e:1: [Alpha canonical company public projection](https://www.alpha.ac/api/public/companies/adagene-inc). - alpha:evidence:company:b925afbb-e483-491c-b195-7a680f06601e:2: [SEC 20-F 0001104659-26-038612](https://www.sec.gov/Archives/edgar/data/1818838/000110465926038612/adag-20251231x20f.htm). ## Rights | Field | Value | | --- | --- | | public_retrieval | allowed | | agent_retrieval | allowed | | redistribution | not_granted | | model_training | not_granted | | commercial_use | not_specified | | relationship_pathfinding | not_granted | | direct_contact | not_granted | ## Limitations - Absence of a leadership role, committee, or disclosure is not evidence that it does not exist. - Only explicitly published canonical company identity and current confirmed public roles are included. - Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist. - Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights. - This Company Profile is an identity and evidence record, not an Alpha rating. - Current index memberships: Unavailable - Index membership events: Unavailable ## Alternate representations - [Canonical profile](https://registry.alpha.ac/companies/adagene-inc) - [Public Markdown](https://registry.alpha.ac/companies/adagene-inc.md) - [Public JSON](https://registry.alpha.ac/api/public/companies/adagene-inc) - [JSON-LD](https://registry.alpha.ac/api/public/companies/adagene-inc?format=jsonld) - MCP resource: `alpha://companies/adagene-inc` at https://mcp.alpha.ac/mcp